Finance

Beta
Ask
Lists
301277:SHE
Newland Pharmaceutical Co Ltd
CN¥9.21
-0.97%
(-0.090) 1D
Jun 15, 3:04:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301277...
Open
CN¥9.30
High
CN¥9.48
Low
CN¥9.17
Mkt. cap
3.65B
Avg. vol.
2.42M
Volume
2.49M
Dividend
2.17%
Quarterly dividend
CN¥0.05
Ex-dividend date
Apr 30, 2026
P/E ratio
35.83
52-wk high
CN¥17.14
52-wk low
CN¥8.98
EPS
CN¥0.26
Shares outstanding
392.08M
No. of employees
981
Open
CN¥9.30
High
CN¥9.48
Low
CN¥9.17
Mkt. cap
3.65B
Avg. vol.
2.42M
Volume
2.49M
Dividend
2.17%
Quarterly dividend
CN¥0.05
Ex-dividend date
Apr 30, 2026
P/E ratio
35.83
52-wk high
CN¥17.14
52-wk low
CN¥8.98
EPS
CN¥0.26
Shares outstanding
392.08M
No. of employees
981
News stories
From sources across the web
About Newland Pharmaceutical Co Ltd
CEO-
Employees981
FoundedSep 15, 2005
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
139.02M
122.43M
191.14M
206.95M
Cost of goods sold
91.69M
83.98M
138.56M
141.52M
Cost of revenue
91.69M
83.98M
138.56M
141.52M
Research and development expenses
15.18M
8.33M
9.79M
6.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.64M
13.48M
16.44M
14.66M
Operating expense
28.34M
22.06M
29.05M
23.97M
Total operating expenses
120.03M
106.04M
167.61M
165.49M
Operating income
18.99M
16.38M
23.53M
41.45M
Other non operating income
324.93K
2.67M
-2.69M
-123.00K
EBT including unusual items
22.58M
15.44M
31.34M
41.72M
EBT excluding unusual items
21.71M
21.71M
22.93M
42.86M
Income tax expense
1.16M
2.11M
2.54M
5.95M
Effective tax rate
5.12%
13.69%
8.12%
14.25%
Other operating expenses
1.51M
1.33M
531.26K
1.86M
Net income
21.46M
13.87M
29.35M
36.10M
Net profit margin
15.44%
11.33%
15.35%
17.44%
Earnings per share
-
-
-
-
Interest and investment income
2.40M
2.70M
2.18M
1.57M
Interest expense
-
-51.38K
-48.10K
-34.88K
Net interest expenses
2.40M
2.65M
2.13M
1.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
31.54M
25.16M
36.67M
54.59M
Gain or loss from assets sale
466.62K
-466.62K
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more